Diabetes drug shows promise in multiple sclerosis
Key points
- Treatment with the diabetes drug Actos, known technically as pioglitazone, seems to reduce brain shrinkage and may have other beneficial effects in people with multiple sclerosis (MS), researchers report.
- If confirmed, this drug or one in the same class might be useful as add-on treatment for people with MS, Dr.
- Feinstein, at the University of Illinois, Chicago, and colleagues came to this conclusion after studying 21 patients with so-called "relapsing-remitting" MS who were randomly assigned to take 30 milligrams of pioglitazone daily or an inactive "placebo".
- As reported in the Journal of Neuroimmunology, after a year, there were no significant differences between the two groups in clinical symptoms.
Treatment with the diabetes drug Actos, known technically as pioglitazone, seems to reduce brain shrinkage and may have other beneficial effects in people with multiple sclerosis (MS), researchers report.
If confirmed, this drug or one in the same class might be useful as add-on treatment for people with MS, Dr. Douglas L. Feinstein told Reuters Health.
Feinstein, at the University of Illinois, Chicago, and colleagues came to this conclusion after studying 21 patients with so-called "relapsing-remitting" MS who were randomly assigned to take 30 milligrams of pioglitazone daily or an inactive "placebo".
As reported in the Journal of Neuroimmunology, after a year, there were no significant differences between the two groups in clinical symptoms. However, MRI scans showed a significant reduction in gray matter loss and a trend toward fewer brain lesions in the active treatment group.
Feinstein noted that the class of drugs that includes pioglitazone "is currently being tested by several different labs around the world, in other neurological diseases including Alzheimer's disease, Parkinson's diseases, ALS, and stroke."
He concluded, "Our findings of possible neuroprotective effects might be applicable to those other conditions."
SOURCE: Journal of Neuroimmunology, online May 26, 2009.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Diabetes & Hormones →
NewsAntipsychotic drug use in children for mood/behavior disorders increases type 2 diabetes risk
Prescribing of "atypical" antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center…
22 August 2013
NewsType 1 diabetes drug strikingly effective in clinical trial
An experimental drug designed to block the advance of type 1 diabetes in its earliest stages has proven strikingly effective over two years in about half of the patients who participated in the phase 2 clinical trial.…
8 August 2013
NewsStudy shows community approach effective in fight against diabetes
New research from Wake Forest Baptist Medical Center shows that a diabetes prevention program led by community health workers is effective at reducing blood glucose and potentially reducing diabetes over the long term.…
